Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - Deutsche Boerse Ag - US5500211090 - Common Stock - Currency: EUR

198  -1.02 (-0.51%)

Fundamental Rating

7

Taking everything into account, 33L scores 7 out of 10 in our fundamental rating. 33L was compared to 43 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 33L a very profitable company, without any liquidiy or solvency issues. 33L is not valued too expensively and it also shows a decent growth rate. With these ratings, 33L could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
33L had a positive operating cash flow in the past year.
Each year in the past 5 years 33L has been profitable.
In the past 5 years 33L always reported a positive cash flow from operatings.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 24.33%, 33L belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 42.14%, 33L belongs to the top of the industry, outperforming 97.67% of the companies in the same industry.
33L has a better Return On Invested Capital (30.39%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 33L is significantly above the industry average of 10.38%.
The last Return On Invested Capital (30.39%) for 33L is above the 3 year average (29.73%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 24.33%
ROE 42.14%
ROIC 30.39%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

33L has a better Profit Margin (16.82%) than 90.70% of its industry peers.
33L's Profit Margin has been stable in the last couple of years.
33L's Operating Margin of 23.37% is amongst the best of the industry. 33L outperforms 90.70% of its industry peers.
33L's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 59.34%, 33L perfoms like the industry average, outperforming 44.19% of the companies in the same industry.
In the last couple of years the Gross Margin of 33L has remained more or less at the same level.
Industry RankSector Rank
OM 23.37%
PM (TTM) 16.82%
GM 59.34%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 33L is creating value.
The number of shares outstanding for 33L remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 33L has less shares outstanding
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 8.92. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.92, 33L belongs to the best of the industry, outperforming 90.70% of the companies in the same industry.
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.92
ROIC/WACC3.82
WACC7.95%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

33L has a Current Ratio of 2.28. This indicates that 33L is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.28, 33L belongs to the best of the industry, outperforming 81.40% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that 33L should not have too much problems paying its short term obligations.
33L has a better Quick ratio (1.23) than 72.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 1.23
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.19% over the past year.
Measured over the past years, 33L shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.37% on average per year.
The Revenue has grown by 9.39% in the past year. This is quite good.
33L shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.62% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%2.36%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.32%

3.2 Future

The Earnings Per Share is expected to grow by 11.19% on average over the next years. This is quite good.
Based on estimates for the next years, 33L will show a small growth in Revenue. The Revenue will grow by 7.99% on average per year.
EPS Next Y1.24%
EPS Next 2Y4.26%
EPS Next 3Y4.98%
EPS Next 5Y11.19%
Revenue Next Year6.49%
Revenue Next 2Y6.7%
Revenue Next 3Y6.51%
Revenue Next 5Y7.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.63 indicates a correct valuation of 33L.
33L's Price/Earnings ratio is a bit cheaper when compared to the industry. 33L is cheaper than 74.42% of the companies in the same industry.
33L is valuated rather cheaply when we compare the Price/Earnings ratio to 27.46, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.44 indicates a correct valuation of 33L.
Based on the Price/Forward Earnings ratio, 33L is valued a bit cheaper than the industry average as 79.07% of the companies are valued more expensively.
33L's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 15.63
Fwd PE 14.44
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 33L indicates a somewhat cheap valuation: 33L is cheaper than 60.47% of the companies listed in the same industry.
65.12% of the companies in the same industry are cheaper than 33L, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.02
EV/EBITDA 8.84
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 33L does not grow enough to justify the current Price/Earnings ratio.
33L has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)12.61
PEG (5Y)0.64
EPS Next 2Y4.26%
EPS Next 3Y4.98%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (7/18/2025, 7:00:00 PM)

198

-1.02 (-0.51%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)06-05 2025-06-05/amc
Earnings (Next)08-27 2025-08-27/amc
Inst Owners96.5%
Inst Owner ChangeN/A
Ins Owners0.3%
Ins Owner ChangeN/A
Market Cap23.73B
Analysts74
Price Target273.53 (38.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-1.37%
Max EPS beat(2)2.91%
EPS beat(4)3
Avg EPS beat(4)2.92%
Min EPS beat(4)-1.37%
Max EPS beat(4)5.41%
EPS beat(8)7
Avg EPS beat(8)3.97%
EPS beat(12)10
Avg EPS beat(12)5.1%
EPS beat(16)14
Avg EPS beat(16)6.97%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.92%
Revenue beat(4)0
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)4
Avg Revenue beat(12)-0.36%
Revenue beat(16)6
Avg Revenue beat(16)0.12%
PT rev (1m)-7.97%
PT rev (3m)-22.16%
EPS NQ rev (1m)-0.4%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)-0.48%
EPS NY rev (3m)-1.81%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 15.63
Fwd PE 14.44
P/S 2.57
P/FCF 21.02
P/OCF 13.64
P/B 6.44
P/tB 6.72
EV/EBITDA 8.84
EPS(TTM)12.67
EY6.4%
EPS(NY)13.72
Fwd EY6.93%
FCF(TTM)9.42
FCFY4.76%
OCF(TTM)14.51
OCFY7.33%
SpS76.99
BVpS30.72
TBVpS29.45
PEG (NY)12.61
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 24.33%
ROE 42.14%
ROCE 42.89%
ROIC 30.39%
ROICexc 39.27%
ROICexgc 40.88%
OM 23.37%
PM (TTM) 16.82%
GM 59.34%
FCFM 12.24%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 152.77%
Cap/Sales 6.61%
Interest Coverage 250
Cash Conversion 68.04%
Profit Quality 72.77%
Current Ratio 2.28
Quick Ratio 1.23
Altman-Z 8.92
F-Score8
WACC7.95%
ROIC/WACC3.82
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%2.36%
EPS Next Y1.24%
EPS Next 2Y4.26%
EPS Next 3Y4.98%
EPS Next 5Y11.19%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.32%
Revenue Next Year6.49%
Revenue Next 2Y6.7%
Revenue Next 3Y6.51%
Revenue Next 5Y7.99%
EBIT growth 1Y12.25%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year21.76%
EBIT Next 3Y12.04%
EBIT Next 5Y10.61%
FCF growth 1Y122.59%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y61.42%
OCF growth 3Y17.83%
OCF growth 5Y27.7%